🌍·3d agoResearch
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- June 23, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
UNMC/5h ago
UNMC announces spring 2026 dean’s list
Universitätsspital Zürich (USZ)/7h ago
Patientendaten für die Forschung – Der Wert der Zustimmung
Policlinico di Milano/8h ago
#PASSAPAROLA. Prosegue l'emergenza caldo 2026: come proteggersi
UFRJ Brazil/3h ago